Sushil Kumar Singh Selected Research

Sushil Kumar Singh Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 10/2012
7	Neoplasms (Cancer) 01/2020 - 06/2011
6	Amnesia (Dissociative Amnesia) 01/2024 - 06/2012
4	Cognitive Dysfunction 02/2024 - 01/2016
4	Body Weight (Weight, Body) 10/2022 - 01/2012
3	Parkinson Disease (Parkinson's Disease) 02/2023 - 01/2022
2	Neuroinflammatory Diseases 12/2023 - 12/2021
2	Relapsing-Remitting Multiple Sclerosis 08/2023 - 07/2023
2	Necrosis 07/2023 - 01/2022
2	Dementia (Dementias) 12/2022 - 12/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
2	Amyloid Plaque 01/2022 - 03/2018
2	Hypoxia (Hypoxemia) 01/2016 - 01/2013
2	Inflammation (Inflammations) 09/2014 - 01/2013
2	Malaria 12/2013 - 03/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2013 - 10/2012
2	Asthma (Bronchial Asthma) 02/2013 - 10/2012
2	Arthritis (Polyarthritis) 02/2013 - 10/2012
2	Ulcer 02/2013 - 10/2012
2	Mental Disorders (Mental Disorder) 06/2012 - 04/2008
2	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2012 - 04/2008
1	Skin Diseases (Skin Disease) 02/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Autistic Disorder (Autism) 12/2022
1	Nervous System Diseases (Neurological Disorders) 12/2022
1	Arsenic Poisoning 10/2022
1	Thrombosis (Thrombus) 01/2022
1	Ischemic Stroke 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Pneumopericardium 07/2019
1	Pericardial Effusion 07/2019
1	Infections 01/2019
1	Gas Gangrene (Gangrene, Gas) 02/2018

Drug/Important Bio-Agent (IBA)

6	Amyloid (Amyloid Fibrils)IBA 03/2024 - 10/2021
6	Scopolamine (Hyoscine)FDA Link 01/2024 - 06/2012
5	EnzymesIBA 03/2024 - 03/2013
3	LigandsIBA 01/2024 - 11/2019
3	Cholinergic Agents (Cholinergics)IBA 12/2022 - 01/2019
3	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 06/2011
2	Cathepsin BIBA 03/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2013
2	AntioxidantsIBA 02/2024 - 07/2023
2	Dimethyl FumarateIBA 08/2023 - 07/2023
2	Interleukin-6 (Interleukin 6)IBA 07/2023 - 01/2022
2	AlkaloidsIBA 03/2023 - 01/2023
2	Glucosylceramidase (Glucocerebrosidase)IBA 02/2023 - 01/2022
2	CytokinesIBA 01/2022 - 12/2021
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2021 - 03/2018
2	ceric oxide (cerium dioxide)IBA 01/2016 - 01/2013
2	CurcuminIBA 03/2013 - 10/2012
1	asiatic acidIBA 02/2024
1	Cholinergic Antagonists (Anticholinergics)IBA 02/2024
1	DiureticsIBA 02/2024
1	madecassic acidIBA 02/2024
1	PiperazineIBA 01/2024
1	Chalcone (Benzalacetophenone)IBA 01/2024
1	InflammasomesIBA 12/2023
1	Leucine (L-Leucine)FDA Link 12/2023
1	NLR ProteinsIBA 12/2023
1	NucleotidesIBA 12/2023
1	CoumarinsIBA 12/2023
1	TriazolesIBA 11/2023
1	AdamantaneIBA 11/2023
1	CRISPR-Associated Protein 9IBA 10/2023
1	LipopolysaccharidesIBA 07/2023
1	Histone Deacetylase 2IBA 06/2023
1	vasicineIBA 03/2023
1	pyrrolidineIBA 03/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	piperineIBA 01/2023
1	piperidineIBA 01/2023
1	AluminumIBA 12/2022
1	Aluminum ChlorideIBA 12/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2022
1	sodium arsenite (sodium metaarsenite)IBA 10/2022
1	3,3'-diindolylmethane (diindolylmethane)IBA 01/2022
1	AcidsIBA 01/2022
1	Methanol (Carbinol)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	CaspasesIBA 12/2021
1	Complement System Proteins (Complement)IBA 12/2021
1	ChemokinesIBA 12/2021
1	peptide AIBA 12/2021
1	CarbohydratesIBA 10/2021
1	tau Proteins (tau Protein)IBA 10/2021
1	Cholinesterases (Cholinesterase)IBA 10/2021
1	ArsenicIBA 12/2020
1	AmidesIBA 01/2020
1	EmulsionsIBA 01/2020
1	AnthraquinonesIBA 01/2020
1	benzothiazoleIBA 01/2020
1	Amyloid beta-PeptidesIBA 11/2019
1	AminesIBA 11/2019
1	pyrazoleIBA 01/2019
1	Antitubercular AgentsIBA 01/2019

Therapy/Procedure

2	Therapeutics 01/2024 - 01/2020
2	Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump) 05/2015 - 02/2012
1	Pericardiectomy 07/2019